It’s not Delivery, it’s HNPO.
Posted by naturalproductman on July 3, 2009
Shouheng Sun from Brown University has recently published in JACS on a target delivery of cisplatin to cancer cells using porous hollow nanoparticles (PHNP). They concluded that the nanoparticles deliver the cisplatin better at 2.9 micromolar IC50 towards breast cancer SK-BR-3 while without the nanoparticles, it’s activity is 6.8 micromolar.
